Demis Hassabis is a celebrated name in artificial intelligence research. He’s a chess master and a neuroscientist. On Wall Street, he’s less
Tag: Novartis AG
Stocks making the biggest moves midday: SPOT, JBLU, DHR, GM
Check out the companies making headlines in midday trading. General Motors — Shares rose more than 4% after the automaker exceeded analysts’
GRANOLAS stocks power Europe to record highs, drawing Magnificent 7 comparisons
The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024. Staff | Reuters
Fund manager names 6 stocks to play this lesser-known market
Concerns over worsening geopolitical tensions, volatility in corporate earnings and uncertainty on when the U.S. Federal Reserve will cut interest rates have
Novartis in the lead to acquire cancer drug developer MorphoSys, sources say
Novartis Arnd Wiegmann | Reuters Drug maker Novartis is in advanced talks to acquire MorphoSys, a developer of cancer treatments that has a market
What Jim Cramer is watching to see where the stock market goes next
We don’t know what we want. This week, we will find out what it is that will propel us forward or turn
Jim Cramer’s 4 stock ideas from JPMorgan Healthcare Conference
Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech
Follow CEOs at the JPMorgan Healthcare Conference
CNBC’s Jim Cramer on Friday told investors what to watch for on Wall Street next week, highlighting JPMorgan‘s market-moving health-care conference in
Health sector themes to watch in 2024
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny |
Where M&A could be heading in the obesity drug space
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly
No More Posts Available.
No more pages to load.